Cite

    Proctor, T. et al. (2020). Impact on quality of life and safety of sublingual and subcutaneous immunotherapy in children with severe house dust mite and pollen‐associated allergic rhinoconjunctivitis. Clinical and translational allergy. 10 (1), p. n/a. [Online].